Weight-loss drug approved for people suffering from heart disease

Weight-loss drug approved for people suffering from heart disease

Weight-loss drug, semaglutide has been approved by MHRA as a preventative treatment for people with a BMI of 27 or over who suffer from established cardiovascular disease

Thursday, 8 August 2024, Steve Smethurst

Person viewing EHN Jobs website on a mobile phone

Looking for a new role in environmental health?

Whether you're just starting out or ready for your next step, EHN Jobs connects you with the latest opportunities in environmental health across the UK.